Mesenchymal stem cell implantation in atrophic nonunion of the long bones: A translational study
- PMID: 27412657
- PMCID: PMC4957179
- DOI: 10.1302/2046-3758.57.2000587
Mesenchymal stem cell implantation in atrophic nonunion of the long bones: A translational study
Abstract
Objectives: To explore the therapeutic potential of combining bone marrow-derived mesenchymal stem cells (BM-MSCs) and hydroxyapatite (HA) granules to treat nonunion of the long bone.
Methods: Ten patients with an atrophic nonunion of a long bone fracture were selectively divided into two groups. Five subjects in the treatment group were treated with the combination of 15 million autologous BM-MSCs, 5g/cm(3) (HA) granules and internal fixation. Control subjects were treated with iliac crest autograft, 5g/cm(3) HA granules and internal fixation. The outcomes measured were post-operative pain (visual analogue scale), level of functionality (LEFS and DASH), and radiograph assessment.
Results: Post-operative pain evaluation showed no significant differences between the two groups. The treatment group demonstrated faster initial radiographic and functional improvements. Statistically significant differences in functional scores were present during the first (p = 0.002), second (p = 0.005) and third (p = 0.01) month. Both groups achieved similar outcomes by the end of one-year follow-up. No immunologic or neoplastic side effects were reported.
Conclusions: All cases of nonunion of a long bone presented in this study were successfully treated using autologous BM-MSCs. The combination of autologous BM-MSCs and HA granules is a safe method for treating nonunion. Patients treated with BM-MSCs had faster initial radiographic and functional improvements. By the end of 12 months, both groups had similar outcomes.Cite this article: H.D. Ismail, P. Phedy, E. Kholinne, Y. P. Djaja, Y. Kusnadi, M. Merlina, N. D. Yulisa. Mesenchymal stem cell implantation in atrophic nonunion of the long bones: A translational study. Bone Joint Res 2016;5:287-293. DOI: 10.1302/2046-3758.57.2000587.
Keywords: Atrophic nonunion of the long bones; Bone marrow-derived mesenchymal stem cells (BM-MSCs); Hydroxyapatite (HA) granules.
© 2016 Ismail et al.
Conflict of interest statement
Figures
Similar articles
-
Autologous mesenchymal stem cell implantation, hydroxyapatite, bone morphogenetic protein-2, and internal fixation for treating critical-sized defects: a translational study.Int Orthop. 2019 Jun;43(6):1509-1519. doi: 10.1007/s00264-019-04307-z. Epub 2019 Feb 12. Int Orthop. 2019. PMID: 30747273 Free PMC article.
-
Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bones: a phase II clinical trial.J Transl Med. 2024 May 24;22(1):493. doi: 10.1186/s12967-024-05280-x. J Transl Med. 2024. PMID: 38789992 Free PMC article. Clinical Trial.
-
Existence of mesenchymal stem cellsin sites of atrophic nonunion.Bone Joint Res. 2013 Jun 19;2(6):112-5. doi: 10.1302/2046-3758.26.2000165. Print 2013. Bone Joint Res. 2013. PMID: 23836475 Free PMC article.
-
Autologous mesenchymal stem cell (MSCs) transplantation for critical-sized bone defect following a wide excision of osteofibrous dysplasia.Int J Surg Case Rep. 2015;17:106-11. doi: 10.1016/j.ijscr.2015.10.040. Epub 2015 Nov 5. Int J Surg Case Rep. 2015. PMID: 26599503 Free PMC article.
-
Bone marrow aspirate and bone marrow aspirate concentrate: Does the literature support use in long-bone nonunion and provide new insights into mechanism of action?Eur J Orthop Surg Traumatol. 2024 Aug;34(6):2871-2880. doi: 10.1007/s00590-024-04048-9. Epub 2024 Jul 26. Eur J Orthop Surg Traumatol. 2024. PMID: 39060552 Free PMC article. Review.
Cited by
-
Systematic review assessing the evidence for the use of stem cells in fracture healing.Bone Jt Open. 2020 Oct 6;1(10):628-638. doi: 10.1302/2633-1462.110.BJO-2020-0129. eCollection 2020 Oct. Bone Jt Open. 2020. PMID: 33215094 Free PMC article.
-
Defective Proliferation and Osteogenic Potential with Altered Immunoregulatory phenotype of Native Bone marrow-Multipotential Stromal Cells in Atrophic Fracture Non-Union.Sci Rep. 2019 Nov 22;9(1):17340. doi: 10.1038/s41598-019-53927-3. Sci Rep. 2019. PMID: 31758052 Free PMC article.
-
A Multicentric, Open-Label, Randomized, Comparative Clinical Trial of Two Different Doses of Expanded hBM-MSCs Plus Biomaterial versus Iliac Crest Autograft, for Bone Healing in Nonunions after Long Bone Fractures: Study Protocol.Stem Cells Int. 2018 Feb 22;2018:6025918. doi: 10.1155/2018/6025918. eCollection 2018. Stem Cells Int. 2018. PMID: 29535772 Free PMC article.
-
Equipoise and the technology curve: Relevance in the design of Surgical trials.Bone Joint Res. 2016 Oct;5(10):520-522. doi: 10.1302/2046-3758.510.2000655. Bone Joint Res. 2016. PMID: 27784670 Free PMC article. No abstract available.
-
Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach.Stem Cells Int. 2017;2017:3674045. doi: 10.1155/2017/3674045. Epub 2017 Jun 20. Stem Cells Int. 2017. PMID: 28744314 Free PMC article.
References
-
- Al-Hadithy N, Sewell MD, Bhavikatti M, Gikas PD. The effect of smoking on fracture healing and on various orthopaedic procedures. Acta Orthop Belg 2012;78:285-290. - PubMed
-
- Gustilo RB, Mendoza RM, Williams DN. Problems in the management of type III (severe) open fractures: a new classification of type III open fractures. J Trauma 1984;24:742-746. - PubMed
-
- Reverte MM, Dimitriou R, Kanakaris NK, Giannoudis PV. What is the effect of compartment syndrome and fasciotomies on fracture healing in tibial fractures? Injury 2011;42:1402-1407. - PubMed
-
- Dahabreh Z, Dimitriou R, Giannoudis PV. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury 2007;38:371-377. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources